Ardent Health (NYSE:ARDT – Get Free Report)‘s stock had its “outperform” rating reissued by Leerink Partners in a research report issued to clients and investors on Friday, September 18th, Benzinga reports. They currently have a $14.00 price target on the stock. Leerink Partners’ price objective suggests a potential upside of 32.51% from the company’s previous close.
A number of other analysts also recently issued reports on ARDT. Truist Financial lifted their price target on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Guggenheim lifted their price target on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Weiss Ratings downgraded Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price target on shares of Ardent Health in a report on Thursday, August 6th. Finally, Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a report on Monday, September 7th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Ardent Health has an average rating of “Hold” and an average price target of $12.79.
Read Our Latest Research Report on ARDT
Ardent Health Stock Up 0.8%
Ardent Health (NYSE:ARDT – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, sell-side analysts anticipate that Ardent Health will post 0.96 earnings per share for the current fiscal year.
Institutional Trading of Ardent Health
Hedge funds and other institutional investors have recently made changes to their positions in the company. The Manufacturers Life Insurance Company increased its position in Ardent Health by 3.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock valued at $255,000 after acquiring an additional 1,072 shares during the period. Allworth Financial LP increased its position in Ardent Health by 131.3% in the 2nd quarter. Allworth Financial LP now owns 2,863 shares of the company’s stock valued at $28,000 after acquiring an additional 1,625 shares during the period. Caitong International Asset Management Co. Ltd increased its position in Ardent Health by 2,036.6% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,786 shares of the company’s stock valued at $42,000 after acquiring an additional 4,562 shares during the period. Integrated Wealth Concepts LLC acquired a new position in Ardent Health in the 2nd quarter valued at about $57,000. Finally, Monetary Solutions Ltd acquired a new position in Ardent Health in the 4th quarter valued at about $79,000.
About Ardent Health
Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.
Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.
See Also
- Five stocks we like better than Ardent Health
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
